ISIN | CH1318028961 |
---|---|
Valor Number | 131802896 |
Bloomberg Global ID | |
Fund Name | Swiss Life Index Funds (CH) Equity Responsible Switzerland All Cap AM Cap |
Fund Provider |
Swiss Life Asset Management AG
Zürich, Switzerland Phone: +41 44 284 77 09 E-Mail: info@swisslife-am.com Web: www.swisslife-am.com |
Fund Provider | Swiss Life Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Swiss Life AG Zürich Phone: +41 43 284 33 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of this sub-fund is to achieve an appropriate investment return in the unit of account by tracking the SPI® ESG Total Return benchmark. Instead of investing in all securities of the benchmark, the fund management company can pick a representative sample (optimised sampling). The selection is made using a system that takes into account quantitative factors determining returns. In addition to the investment restrictions listed below and other legal and regulatory restrictions, reasons for limiting the portfolio to a representative sample of benchmark securities may also include the costs and expenses incurred by the sub-fund and the illiquidity of certain investments. These optimisation strategies may include holding securities at ratios different from the benchmark and/or using derivatives to track the performance of certain securities included in the benchmark. |
Peculiarities |
Current Price * | 1,058.91 CHF | 24.07.2025 |
---|---|---|
Previous Price * | 1,059.57 CHF | 23.07.2025 |
52 Week High * | 1,096.28 CHF | 03.03.2025 |
52 Week Low * | 922.61 CHF | 09.04.2025 |
NAV * | 1,058.91 CHF | 24.07.2025 |
Issue Price * | 1,058.91 CHF | 24.07.2025 |
Redemption Price * | 1,058.91 CHF | 24.07.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 784,910,153 | |
Unit/Share Assets *** | 104,669 | |
Trading Information SIX |
YTD Performance | +8.43% |
31.12.2024 - 24.07.2025
31.12.2024 24.07.2025 |
---|---|---|
1 month | +1.44% |
24.06.2025 - 24.07.2025
24.06.2025 24.07.2025 |
3 months | +3.74% |
24.04.2025 - 24.07.2025
24.04.2025 24.07.2025 |
6 months | +2.48% |
24.01.2025 - 24.07.2025
24.01.2025 24.07.2025 |
1 year | +3.35% |
24.07.2024 - 24.07.2025
24.07.2024 24.07.2025 |
2 years | +6.36% |
29.05.2024 - 24.07.2025
29.05.2024 24.07.2025 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 13.10% | |
---|---|---|
Novartis AG Registered Shares | 12.18% | |
Roche Holding AG | 11.71% | |
Zurich Insurance Group AG | 5.24% | |
UBS Group AG Registered Shares | 5.20% | |
Compagnie Financiere Richemont SA Class A | 5.18% | |
ABB Ltd | 4.82% | |
Lonza Group Ltd | 2.63% | |
Swiss Re AG | 2.61% | |
Alcon Inc | 2.26% | |
Last data update | 30.06.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |